Company intelligence / Profile preview

Avegen

London, England, United Kingdomavegenhealth.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Avegen’s digital health products are used by over 2 million patients globally to support self-management and improve care delivery in chronic and long-term conditions. The company partners with major pharmaceutical companies, research institutes, and healthcare providers to deliver evidence-backed digital solutions that enhance patient engagement and operational efficiency. Their platform is ISO13485 certified for device quality management.

Therapeutic areas: NeurologyPsychiatryWomen's HealthInfectious DiseasesEndocrinologyOncologyCardiovascular
Modalities: DeviceNon-pharmacological therapyDigital therapeutic
Industry: Digital Health Medical Devices

Partnerships

Major pharmaceutical companiesNHS Integrated Care Boards such as Bucks/Oxford/West Berkshire ICBresearch instituteshealthcare providers globally

Beyond the preview

Go deeper on Avegen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avegen.

Explore the full profile